We appreciate the interest by Meng and Wang (1) in our article (2), which highlights the need to conduct a competing risk analysis between all-cause mortality, type 2 diabetes, and risk of Alzheimer disease, as the early average mortality experienced by patients with diabetes compared with controls could explain the inverse associations reported in our study. We completely agree; this is why our study already included all-cause mortality in competing risk analyses (2). As described in our methods and results section, the inverse association is indeed explained by the early mortality experienced in patients with diabetes compared with controls, which reduced the probability of developing Alzheimer disease (2). That noted, vascular dementia rates were meaningfully higher in people with diabetes, irrespective of competing risks, a novel observation that suggests targeting vascular risk factors in patients with diabetes should not only lessen cardiovascular outcomes but also slow cognitive decline. More trials in this area would be beneficial.
Response to Comment on Celis-Morales et al. Type 2 Diabetes, Glycemic Control, and Their Association With Dementia and Its Major Subtypes: Findings From the Swedish National Diabetes Register. Diabetes Care 2022;45:634–641
Wellicht vindt u dit ook interessant
Meld u aan voor de maandelijkse nieuwsbrief
Categorieën
- Aanbevolen door de redactie3
- ADA 201818
- ADA 201931
- ADA 202016
- ADA 202120
- ADA 20222
- ADDRM 201611
- ADDRM 20176
- ADDRM 20188
- ATTD 20199
- ATTD 20209
- ATTD 202212
- Congresnieuws209
- Corona17
- E-learning18
- EASD 201716
- EASD 201852
- EASD 201933
- EASD 202019
- EASD 202123
- EASD 202235
- Geen categorie17
- Korte educatie video's172
- Nascholing1
- Nieuws535
- Opinie2
- Podcasts15
- Proefschrift van de maand6
- Updates1.564
- Verdieping5